Subsequently, other studies clarified that PARP1 is more active in cancer cells that, due to the lack of function of ATM, accumulated DNA damage (most represented and studied in prostate cancer, breast cancer, mantle cell lymphoma) [65, 87, 88]. The gene discussed is PARP1; the disease is breast cancer.